Mechanism of action of posttransplantation cyclophosphamide: more than meets the eye

由 Radojcic, Vedran, Luznik, Leo
發表在 J Clin Invest (2019)

High-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantation

由 Luznik, Leo, Fuchs, Ephraim J.
出版 2010

Are Alternative Donors Really Still “Alternative?”

由 Kanakry, Christopher G., Luznik, Leo
發表在 Biol Blood Marrow Transplant (2014)

Might haplo “be the (better) match”?

由 Kanakry, Jennifer A., Luznik, Leo
發表在 Blood (2016)

How we perform haploidentical stem cell transplantation with posttransplant cyclophosphamide

由 McCurdy, Shannon R., Luznik, Leo
發表在 Blood (2019)

How we perform haploidentical stem cell transplantation with posttransplant cyclophosphamide

由 McCurdy, Shannon R., Luznik, Leo
發表在 Hematology Am Soc Hematol Educ Program (2019)

Situational aldehyde dehydrogenase expression by regulatory T cells may explain the contextual duality of cyclophosphamide as both a pro-inflammatory and tolerogenic agent

由 Kanakry, Christopher G, Ganguly, Sudipto, Luznik, Leo
發表在 Oncoimmunology (2015)

High dose cyclophosphamide for GVHD prevention

由 Luznik, Leo, Jones, Richard J., Fuchs, Ephraim J.
出版 2010

Modern approaches to HLA-haploidentical blood or marrow transplantation

由 Kanakry, Christopher G., Fuchs, Ephraim J., Luznik, Leo
發表在 Nat Rev Clin Oncol (2015)

Post-transplantation cyclophosphamide for tolerance induction in HLA-haploidentical BMT

由 Luznik, Leo, O’Donnell, Paul V., Ephraim, J. Fuchs
出版 2012

Alternative donor allogeneic hematopoietic cell transplantation for acute myeloid leukemia

由 Kanakry, Christopher G., de Lima, Marcos J., Luznik, Leo
發表在 Semin Hematol (2015)

Immunomodulatory Drugs: Immune Checkpoint Agents in Acute Leukemia

由 Knaus, Hanna A., Kanakry, Christopher G., Luznik, Leo, Gojo, Ivana
發表在 Curr Drug Targets (2017)

How do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation?

由 Chang, Ying-Jun, Luznik, Leo, Fuchs, Ephraim J., Huang, Xiao-Jun
發表在 J Hematol Oncol (2016)

Haploidentical bone marrow and stem cell transplantation: experience with post-transplantation cyclophosphamide

由 Robinson, Tara M., O’Donnell, Paul V., Fuchs, Ephraim J., Luznik, Leo
發表在 Semin Hematol (2016)

Post-transplantation Cyclophosphamide: From HLA-Haploidentical to Matched-Related and Matched-Unrelated Donor Blood and Marrow Transplantation

由 Williams, Louis, Cirrone, Frank, Cole, Kelli, Abdul-Hay, Maher, Luznik, Leo, Al-Homsi, Ahmad Samer
發表在 Front Immunol (2020)

Factors governing the activation of adoptively transferred donor T cells infused after allogeneic bone marrow transplantation in the mouse

由 Durakovic, Nadira, Radojcic, Vedran, Skarica, Mario, Bezak, Karl B., Powell, Jonathan D., Fuchs, Ephraim J., Luznik, Leo
出版 2007

Cyclophosphamide resets dendritic cell homeostasis and enhances antitumor immunity through effects that extend beyond regulatory T cell elimination

由 Radojcic, Vedran, Bezak, Karl B., Skarica, Mario, Pletneva, Maria A., Yoshimura, Kiyoshi, Schulick, Richard D., Luznik, Leo
出版 2009

Induction of MHC-mismatched Mouse Lung Allograft Acceptance with Combined Donor Bone Marrow: Lung Transplant using a 12-Hour Nonmyeloablative Conditioning Regimen

由 Dodd-o, Jeffrey M., Ganguly, Sudipto, Vulic, Ante, Panoskaltsis-Mortari, Angela, McDyer, John F., Luznik, Leo
發表在 Transplantation (2016)

Nonmyeloablative, HLA-haploidentical bone marrow transplantation with high dose, post-transplantation cyclophosphamide

由 Munchel, Ashley, Kesserwan, Chimen, Symons, Heather J., Luznik, Leo, Kasamon, Yvette L., Jones, Richard J., Fuchs, Ephraim J.
出版 2011

IMPS-31 FOCAL BRAIN RADIATION INDUCES SYSTEMIC LYMPHOPENIA IN MICE

由 Piotrowski, Anna, Nirschl, Thomas, Velarde, Esteban, Blosser, Lee, Ganguly, Sudipto, Luznik, Leo, Wong, John, Drake, Charles, Grossman, Stuart
發表在 Neuro Oncol (2015)